TOPCMB

Goldman job cuts hit investment banking and global markets hard

Massive layoffs and spending review for the Wall Street giant Cups in all major divisions expected, globally Asian wealth unit restructuring kicks off Wednesday layoffs NEW YORK/LONDON/HONG KONG, Jan 12 (Reuters) – Goldman Sachs (GS.N) began laying off staff on Wednesday as part of a sweeping cost-cutting campaign, with around a third of those affected …

Goldman job cuts hit investment banking and global markets hard Read More »

Oil gains 2% on optimism over global economy, despite surprise U.S. crude build

NEW YORK, Jan 11 (Reuters) – Oil prices rose 2% on Wednesday to a week-long high as hopes for an improving global economic outlook and concerns over the impact of sanctions on the Russian crude production outweighed a surprise massive increase in US crude inventories. . Brent crude futures rose $1.67, or 2.1%, to $81.77 …

Oil gains 2% on optimism over global economy, despite surprise U.S. crude build Read More »

Biden’s climate agenda has a problem: Not enough workers

Jan 11 (Reuters) – U.S. clean energy companies are offering better wages and benefits, bringing in trainers from abroad and considering ideas such as buying roofs and electrical repair shops just to hire their workers as companies try to overcome a labor shortage that threatens to derail President Joe Biden’s climate change agenda. The Cut …

Biden’s climate agenda has a problem: Not enough workers Read More »

Wall Street rises as Fed’s Powell avoids monetary policy outlook

Broadcom stumbles upon report of Apple’s plan to replace chip Indices up: Dow 0.08%, S&P 0.07%, Nasdaq 0.16% Jan 10 (Reuters) – Major Wall Street indexes rose on Tuesday as Federal Reserve Chairman Jerome Powell avoided commenting on the outlook for monetary policy, with focus on an upcoming inflation reading scheduled for later this week. …

Wall Street rises as Fed’s Powell avoids monetary policy outlook Read More »

Powell: Fed needs independence to fight inflation, should avoid social policy

STOCKHOLM, Jan 10 (Reuters) – The Federal Reserve’s independence from political influence is key to its ability to fight inflation, but requires it to stay clear of issues like that climate change that go beyond its mandate established by Congress, Fed Chairman Jerome Powell said on Tuesday. . “Restoring price stability when inflation is high …

Powell: Fed needs independence to fight inflation, should avoid social policy Read More »

Microsoft in talks to invest $10 billion in ChatGPT owner -Semafor

Jan 9 (Reuters) – Microsoft Corp (MSFT.O) is in talks to invest $10 billion in OpenAI, the owner of ChatGPT, which will value the San Francisco-based company at $29 billion, Semafor reported on Monday, citing people familiar with the matter. The funding includes other venture capitalists and deal documents have been sent to potential investors …

Microsoft in talks to invest $10 billion in ChatGPT owner -Semafor Read More »

Wait times for some Tesla models in China increase after automaker rebates

SHANGHAI, Jan 9 (Reuters) – Potential buyers of Tesla Inc (TSLA.O) in China are waiting longer for some versions of its Model Y car, suggesting the electric vehicle maker’s decision to cut prices is fueling demand on its second largest market. Tesla slashed prices by 6% to 13.5% on Friday, bringing some of its auto …

Wait times for some Tesla models in China increase after automaker rebates Read More »

Shares of ant-related companies rise after news of Jack Mac’s divestment; Alibaba jumps

Jan 9 (Reuters) – Shares of listed Chinese companies that count Ant Group as a major shareholder rose on Monday after news broke that Ant founder Jack Ma was relinquishing control of the fintech giant following a an overhaul. Hong Kong-listed shares of Ma’s Alibaba (9988.HK) jumped 7%. Shares of Longshine Technology Group Co Ltd …

Shares of ant-related companies rise after news of Jack Mac’s divestment; Alibaba jumps Read More »

Eisai and Biogen Receive US FDA Approval for Alzheimer’s Drug and Seek Full Approval

Jan 7 (Reuters) – The U.S. Food and Drug Administration on Friday approved Alzheimer’s disease drug lecanemab, developed by Eisai Co Ltd (4523.T) and Biogen Inc (BIIB.O) for patients in the early stages of mind sickness. Eisai and Biogen said on Saturday that the Japanese drugmaker had sought full FDA approval for the drug. The …

Eisai and Biogen Receive US FDA Approval for Alzheimer’s Drug and Seek Full Approval Read More »